Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca<sup>2+</sup> Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties
Irene Pachón-Angona,
Paul J. Bernard,
Alexey Simakov,
Maciej Maj,
Krzysztof Jozwiak,
Anna Novotna,
Carina Lemke,
Michael Gütschow,
Helene Martin,
María-Jesús Oset-Gasque,
José-Marco Contelles,
Lhassane Ismaili
Affiliations
Irene Pachón-Angona
Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France
Paul J. Bernard
Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France
Alexey Simakov
Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France
Maciej Maj
Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland
Krzysztof Jozwiak
Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland
Anna Novotna
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany
Carina Lemke
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany
Michael Gütschow
Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany
Helene Martin
Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France
María-Jesús Oset-Gasque
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain
José-Marco Contelles
Laboratory of Medicinal Chemistry (IQOG, CSIC) C/Juan de la Cierva 3, 28006 Madrid, Spain
Lhassane Ismaili
Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France
This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.